13 D Management LLC Elanco Animal Health Inc Transaction History

13 D Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$14.37 - $16.46 $7.12 Million - $8.16 Million	495,622 New	495,622 $8.07 Million
Q3 2022 Nov 14, 2022	SELL	$12.41 - $32.42 $700,470 - $1.83 Million	-56,444 Reduced 15.98%	296,839 $3.68 Million
Q2 2022 Aug 15, 2022	BUY	$19.63 - $26.62 $431,094 - $584,601	21,961 Added 6.63%	353,283 $6.94 Million
Q1 2022 May 16, 2022	SELL	$24.65 - $29.0 $721,554 - $848,888	-29,272 Reduced 8.12%	331,322 $8.64 Million
Q4 2021 Feb 14, 2022	SELL	$27.74 - $34.09 $613,497 - $753,934	-22,116 Reduced 5.78%	360,594 $10.2 Million
Q2 2021 Aug 16, 2021	BUY	$28.76 - $35.98 $2.38 Million - $2.97 Million	82,600 Added 27.52%	382,710 $13.3 Million
Q1 2021 May 17, 2021	BUY	$27.85 - $34.49 $727,163 - $900,533	26,110 Added 9.53%	300,110 $8.84 Million
Q4 2020 Feb 16, 2021	BUY	$27.53 - $33.79 $7.54 Million - $9.26 Million	274,000 New	274,000 $8.4 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of 13 D Management LLC, based on Form 13F filings with the SEC.

Stay updated on 13 D Management LLC with notifications on news.